845866-81-1 Usage
General Description
2-BROMO-1-DIFLUOROMETHYL-4-FLUOROBENZENE is a chemical compound with the molecular formula C7H4BrF3. It is a clear, colorless liquid that is commonly used as an intermediate in the production of pharmaceuticals and agrochemicals. 2-BROMO-1-DIFLUOROMETHYL-4-FLUOROBENZENE is primarily used as a building block in the synthesis of various organic compounds due to its unique properties. It is a highly reactive compound with a wide range of applications in the chemical industry. Its structure consists of a benzene ring with a bromine atom at the 2-position, a difluoromethyl group at the 1-position, and a fluorine atom at the 4-position. The compound is known for its stability and relatively low toxicity, making it a valuable component in the synthesis of complex organic molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 845866-81-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,5,8,6 and 6 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 845866-81:
(8*8)+(7*4)+(6*5)+(5*8)+(4*6)+(3*6)+(2*8)+(1*1)=221
221 % 10 = 1
So 845866-81-1 is a valid CAS Registry Number.
InChI:InChI=1/C7H4BrF3/c8-6-3-4(9)1-2-5(6)7(10)11/h1-3,7H
845866-81-1Relevant articles and documents
FUSED IMIDAZOLE DERIVATIVES AS AHR ANTAGONISTS
-
Paragraph 00104; 00116, (2021/11/26)
The present disclosure relates to compounds of formulae (I) - (VI) and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the same, methods of preparing the same, intermediate compounds useful for preparing the same, and methods for treating or prophylaxis of diseases, in particular cancer or conditions with dysregulated immune responses or other disorders associated with aberrant AHR signaling.
SUBSTITUTED 2-AMINOPYRIDINE PROTEIN KINASE INHIBITOR
-
Paragraph 0162, (2015/12/19)
Disclosed are a 2-aminopyridine derivative having protein kinase inhibition activity, a preparation method and a pharmaceutical composition thereof Also disclosed are uses of the compounds and the pharmaceutical compositions thereof in the preparation of drugs for treating and/or preventing protein kinase-related diseases.
